SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-182983
Filing Date
2015-05-12
Accepted
2015-05-12 07:15:58
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d901989d10q.htm 10-Q 723850
2 EX-31.1 d901989dex311.htm EX-31.1 5767
3 EX-31.2 d901989dex312.htm EX-31.2 5763
4 EX-32.1 d901989dex321.htm EX-32.1 4160
  Complete submission text file 0001193125-15-182983.txt   4500643

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT fgen-20150331.xml EX-101.INS 578432
6 XBRL TAXONOMY EXTENSION SCHEMA fgen-20150331.xsd EX-101.SCH 37602
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fgen-20150331_cal.xml EX-101.CAL 55999
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fgen-20150331_def.xml EX-101.DEF 116352
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20150331_lab.xml EX-101.LAB 296243
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20150331_pre.xml EX-101.PRE 213280
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 15852764
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences